Cargando…

Superparamagnetic iron oxide-C595: Potential MR imaging contrast agents for ovarian cancer detection

Superparamagnetic iron oxide nanoparticles (SPIONs), have played an important role in the promotion of image contrast in magnetic resonance imaging modality. The objective of present study is describing SPIONs conjugated with C595 monoclonal antibody (mAb) against MUC1-expressing ovarian cancer (OVC...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shahbazi-Gahrouei, Daryoush, Abdolahi, Mohammad
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2013
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3959000/ https://www.ncbi.nlm.nih.gov/pubmed/24672155 http://dx.doi.org/10.4103/0971-6203.121198

Ejemplares similares

Detection of MUC1-Expressing Ovarian Cancer by C595 Monoclonal Antibody-Conjugated SPIONs Using MR Imaging
por: Shahbazi-Gahrouei, Daryoush, et al.
Publicado: (2013)

Erratum: Superparamagnetic Iron Oxide-C595: Potential MR Imaging Contrast Agents for Ovarian Cancer Detection
Publicado: (2020)

Novel MR imaging contrast agents for cancer detection
por: Shahbazi-Gahrouei, Daryoush
Publicado: (2009)

Magnetic Iron Oxide Nanoparticles as T(2) MR Imaging Contrast Agent for Detection of Breast Cancer (MCF-7) Cell
por: Moradi Khaniabadi, Pegah, et al.
Publicado: (2017)

In vitro Study of SPIONs-C595 as Molecular Imaging Probe for Specific Breast Cancer (MCF-7) Cells Detection
por: Khaniabadi, Pegah Moradi, et al.
Publicado: (2017)

The correlation between high background radiation and blood level of the trace elements (copper, zinc, iron and magnesium) in workers of Mahallat's hot springs
por: Shahbazi-Gahrouei, Daryoush, et al.
Publicado: (2012)

Monoclonal antibody A7-superparamagnetic iron oxide as contrast agent of MR imaging of rectal carcinoma
por: Toma, A, et al.
Publicado: (2005)

Aptamer-conjugated Magnetic Nanoparticles as Targeted Magnetic Resonance Imaging Contrast Agent for Breast Cancer
por: Keshtkar, Mohammad, et al.
Publicado: (2016)

Synthesis and Application of Fe(3)O(4)@Au Composite Nanoparticles as Magnetic Resonance/Computed Tomography Dual-Modality Contrast Agent
por: Keshtkar, Mohammad, et al.
Publicado: (2020)

Assessment of Manganese-Zinc Ferrite Nanoparticles as a Novel Magnetic Resonance Imaging Contrast Agent for the Detection of 4T1 Breast Cancer Cells
por: Sobhani, Tayebe, et al.
Publicado: (2019)

Diffusion-Weighted MR Imaging before and after Contrast Enhancement with Superparamagnetic Iron Oxide for Assessment of Hepatic Metastasis
por: Kim, Hana, et al.
Publicado: (2012)

Cobalt Zinc Ferrite Nanoparticles as a Potential Magnetic Resonance Imaging Agent: An In vitro Study
por: Ghasemian, Zeinab, et al.
Publicado: (2015)

Functionalized Magnetic Nanoparticles for the Detection and Quantitative Analysis of Cell Surface Antigen
por: Shahbazi-Gahrouei, Daryoush, et al.
Publicado: (2013)

Comparison of Two Ultrasmall Superparamagnetic Iron Oxides on Cytotoxicity and MR Imaging of Tumors
por: Li, Mulan, et al.
Publicado: (2012)

Advanced Magnetic Resonance Imaging Modalities for Breast Cancer Diagnosis: An Overview of Recent Findings and Perspectives
por: Shahbazi-Gahrouei, Daryoush, et al.
Publicado: (2022)

New MRI contrast agents based on silicon nanotubes loaded with superparamagnetic iron oxide nanoparticles
por: Gonzalez-Rodriguez, Roberto, et al.
Publicado: (2018)

Polymer-coated superparamagnetic iron oxide nanoparticles as T(2) contrast agent for MRI and their uptake in liver
por: Ali, Lamiaa MA, et al.
Publicado: (2017)

Anti-CD24 bio Modified PEGylated Gold Nanoparticles as Targeted Computed Tomography Contrast Agent
por: Ghaziyani, Mona Fazel, et al.
Publicado: (2018)

Contrast-enhanced MR imaging of atherosclerosis using citrate-coated superparamagnetic iron oxide nanoparticles: calcifying microvesicles as imaging target for plaque characterization
por: Wagner, Susanne, et al.
Publicado: (2013)

Mn(ii) chelate-coated superparamagnetic iron oxide nanocrystals as high-efficiency magnetic resonance imaging contrast agents
por: Wu, Changqiang, et al.
Publicado: (2020)

Medical imaging modalities using nanoprobes for cancer diagnosis: A literature review on recent findings
por: Shahbazi-Gahrouei, Daryoush, et al.
Publicado: (2019)

Physicochemical characterization of ultrasmall superparamagnetic iron oxide particles (USPIO) for biomedical application as MRI contrast agents
por: Di Marco, Mariagrazia, et al.
Publicado: (2007)

Superparamagnetic Iron Oxide Nanoparticles as MRI contrast agents for Non-invasive Stem Cell Labeling and Tracking
por: Li, Li, et al.
Publicado: (2013)

Size and PEG Length-Controlled PEGylated Monocrystalline Superparamagnetic Iron Oxide Nanocomposite for MRI Contrast Agent
por: Deng, Li-Hua, et al.
Publicado: (2021)

Determining the optimum tumor control probability model in radiotherapy of glioblastoma multiforme using magnetic resonance imaging data pre- and post- radiation therapy
por: Banisharif, Shabnam, et al.
Publicado: (2022)

Base Transceiver Station Antennae Exposure and Human Health
por: Shahbazi-Gahrouei, Daryoush
Publicado: (2017)

In situ self-assembly of amphiphilic dextran micelles and superparamagnetic iron oxide nanoparticle-loading as magnetic resonance imaging contrast agents
por: Jiang, Linrui, et al.
Publicado: (2022)

Nanovectors for anticancer agents based on superparamagnetic iron oxide nanoparticles
por: Douziech-Eyrolles, Laurence, et al.
Publicado: (2007)

Chitosan–Imidazolium Core–Shell Nanoparticles of Gd-Mn-Mo Polyoxometalate as Novel Potential MRI Nano-Agent for Breast Cancer Detection
por: Aminolroayaei, Fahimeh, et al.
Publicado: (2023)

Ultrasmall cationic superparamagnetic iron oxide nanoparticles as nontoxic and efficient MRI contrast agent and magnetic-targeting tool
por: Uchiyama, Mayara Klimuk, et al.
Publicado: (2015)

Ultra-small superparamagnetic iron oxide contrast agents for lymph node staging of high-risk prostate cancer
por: Czarniecki, Marcin, et al.
Publicado: (2018)

Preparation and characterization of peptide modified ultrasmall superparamagnetic iron oxides used as tumor targeting MRI contrast agent
por: Yin, Jie, et al.
Publicado: (2019)

Non-immunogenic dextran-coated superparamagnetic iron oxide nanoparticles: a biocompatible, size-tunable contrast agent for magnetic resonance imaging
por: Unterweger, Harald, et al.
Publicado: (2017)

Diagnostic Performance Evaluation of Multiparametric Magnetic Resonance Imaging in the Detection of Prostate Cancer with Supervised Machine Learning Methods
por: Nematollahi, Hamide, et al.
Publicado: (2023)

Recent nanotheranostics applications for cancer therapy and diagnosis: A review
por: Aminolroayaei, Fahimeh, et al.
Publicado: (2021)

Evaluation of Targeted Image-Guided Radiation Therapy Treatment Planning System by Use of American Association of Physicists in Medicine Task Group-119 Test Cases
por: Saeb, Mohsen, et al.
Publicado: (2018)

Cyclodextrin-Appended Superparamagnetic Iron Oxide Nanoparticles as Cholesterol-Mopping Agents
por: Puglisi, Antonino, et al.
Publicado: (2021)

Cellular interaction of folic acid conjugated superparamagnetic iron oxide nanoparticles and its use as contrast agent for targeted magnetic imaging of tumor cells
por: Kumar, Manoj, et al.
Publicado: (2012)

Comparison of Three Methods of Calculation, Experimental and Monte Carlo Simulation in Investigation of Organ Doses (Thyroid, Sternum, Cervical Vertebra) in Radioiodine Therapy
por: Shahbazi-Gahrouei, Daryoush, et al.
Publicado: (2012)

Determination of Organ Doses in Radioiodine Therapy using Monte Carlo Simulation
por: Shahbazi-Gahrouei, Daryoush, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_erh5s12ntovis0ttl3gfg4kr9u